Amphastar Pharma (AMPH) Tops Q3 EPS by 1c

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of $0.12, $0.01 better than the analyst estimate of $0.11. Revenue for the quarter came in at $75.5 million versus the consensus estimate of $74.73 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• BofA Securities Downgrades Amphastar Pharmaceuticals (AMPH) to Underperform
• Optical Cable Corporation added to Russell Microcap Index
• SilverCape cuts acquisition bid for PetMed Express to $3 per share